18070361|t|Amyloid precursor protein modulates beta-catenin degradation.
18070361|a|BACKGROUND: The amyloid precursor protein (APP) is genetically associated with Alzheimer's disease (AD). Elucidating the function of APP should help understand AD pathogenesis and provide insights into therapeutic designs against this devastating neurodegenerative disease. RESULTS: We demonstrate that APP expression in primary neurons induces beta-catenin phosphorylation at Ser33, Ser37, and Thr41 (S33/37/T41) residues, which is a prerequisite for beta-catenin ubiquitinylation and proteasomal degradation. APP-induced phosphorylation of beta-catenin resulted in the reduction of total beta-catenin levels, suggesting that APP expression promotes beta-catenin degradation. In contrast, treatment of neurons with APP siRNAs increased total beta-catenin levels and decreased beta-catenin phosphorylation at residues S33/37/T41. Further, beta-catenin was dramatically increased in hippocampal CA1 pyramidal cells from APP knockout animals. Acute expression of wild type APP or of familial AD APP mutants in primary neurons downregulated beta-catenin in membrane and cytosolic fractions, and did not appear to affect nuclear beta-catenin or beta-catenin-dependent transcription. Conversely, in APP knockout CA1 pyramidal cells, accumulation of beta-catenin was associated with the upregulation of cyclin D1, a downstream target of beta-catenin signaling. Together, these data establish that APP downregulates beta-catenin and suggest a role for APP in sustaining neuronal function by preventing cell cycle reactivation and maintaining synaptic integrity. CONCLUSION: We have provided strong evidence that APP modulates beta-catenin degradation in vitro and in vivo. Future studies may investigate whether APP processing is necessary for beta-catenin downregulation, and determine if excessive APP expression contributes to AD pathogenesis through abnormal beta-catenin downregulation.
18070361	0	25	Amyloid precursor protein	Gene	351
18070361	36	48	beta-catenin	Gene	1499
18070361	78	103	amyloid precursor protein	Gene	351
18070361	141	160	Alzheimer's disease	Disease	MESH:D000544
18070361	162	164	AD	Disease	MESH:D000544
18070361	222	224	AD	Disease	MESH:D000544
18070361	309	334	neurodegenerative disease	Disease	MESH:D019636
18070361	407	419	beta-catenin	Gene	1499
18070361	514	526	beta-catenin	Gene	1499
18070361	604	616	beta-catenin	Gene	1499
18070361	652	664	beta-catenin	Gene	1499
18070361	713	725	beta-catenin	Gene	1499
18070361	805	817	beta-catenin	Gene	1499
18070361	839	851	beta-catenin	Gene	1499
18070361	901	913	beta-catenin	Gene	1499
18070361	1052	1054	AD	Disease	MESH:D000544
18070361	1100	1112	beta-catenin	Gene	1499
18070361	1187	1199	beta-catenin	Gene	1499
18070361	1203	1215	beta-catenin	Gene	1499
18070361	1306	1318	beta-catenin	Gene	1499
18070361	1359	1368	cyclin D1	Gene	595
18070361	1393	1405	beta-catenin	Gene	1499
18070361	1471	1483	beta-catenin	Gene	1499
18070361	1681	1693	beta-catenin	Gene	1499
18070361	1799	1811	beta-catenin	Gene	1499
18070361	1885	1887	AD	Disease	MESH:D000544
18070361	1918	1930	beta-catenin	Gene	1499
18070361	Association	MESH:D000544	351
18070361	Association	MESH:D000544	1499
18070361	Positive_Correlation	1499	595
18070361	Association	1499	351

